Substance evaluation - CoRAP

Substance evaluation - CoRAP

Substance evaluation - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
Suspected PMT/vPvM: Potentially Persistent, Mobile and Toxic/very Persistent and very Mobile.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 26 May 2023. Database contains 392 unique substances/entries.
Filter the list
Initial grounds for concern:

The List does not contain any Substances.
 
232-565-6
9000-90-2
2015
United Kingdom
Sensitiser
Consumer use
Exposure of workers
Concluded
Details
231-146-5
7440-36-0
2018
Germany
Suspected Carcinogenic
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Information requested
Details
215-713-4
1345-04-6
2018
Germany
Suspected Carcinogenic
Exposure of workers
High RCR
Other exposure/risk based concern
Wide dispersive use
Information requested
Details
233-047-2
10025-91-9
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Concluded
Details
-
-
2015
Netherlands
Suspected CMR
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
225-935-3
5160-02-1
2020
Germany
Suspected Carcinogenic
Exposure of workers
Wide dispersive use
Concluded
Details
202-860-4
100-52-7
2024
France
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Not started
Details
270-128-1
68411-46-1
2016
Germany
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
309-912-6
101357-15-7
2019
Germany
Suspected PBT/vPvB
Concluded
Details
284-660-7
84961-70-6
2014
Italy
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-337-6
119-61-9
2013
Denmark
Suspected CMR
Consumer use
High RCR
Wide dispersive use
Concluded
Details
205-736-8
149-30-4
2013
Germany
CMR
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-394-1
95-14-7
2016
Germany
Potential endocrine disruptor
Exposure of environment
Follow-up
Details
202-859-9
100-51-6
2016
Germany
Suspected Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
204-262-9
118-58-1
Germany
Potential endocrine disruptor
Withdrawn
Details
231-150-7
7440-41-7
2013
Germany
Other exposure/risk based concern
Concluded
Details
931-700-2
-
2025
France
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
202-163-5
92-52-4
2013
Portugal
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
218-487-5
2162-74-5
2024
Italy
Suspected PBT/vPvB
Exposure of workers
Wide dispersive use
Not started
Details
421-450-8
154702-15-5
2015
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
203-090-1
103-23-1
2020
Finland
Suspected CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
247-426-5
26040-51-7
2019
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Concluded
Details
203-372-4
106-20-7
2019
Portugal
Suspected PBT/vPvB
Exposure of environment
Follow-up
Details
258-469-4
53306-54-0
2020
Germany
Potential endocrine disruptor
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
201-247-9
80-07-9
2019
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
200-237-1
55-55-0
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Concluded
Details
237-695-7
13927-71-4
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of workers
Suspended
Details
254-052-6
38640-62-9
2013
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
700-183-3
52299-25-9
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Concluded
Details
243-001-3
19372-44-2
2015
Germany
Sensitiser
Other hazard based concern
Exposure of workers
High (aggregated) tonnage
Concluded
Details
201-279-3
80-43-3
2015
Norway
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Follow-up
Details
609-946-4
41637-38-1
Germany
Suspected PBT/vPvB
Exposure of environment
Withdrawn
Details
203-450-8
106-99-0
2014
Germany
CMR
Other exposure/risk based concern
Concluded
Details
200-751-6
71-36-3
2017
Hungary
Suspected Reprotoxic
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
245-366-4
22984-54-9
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
218-747-8
2224-33-1
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
308-662-5
98171-53-0
2023
France
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of workers
Ongoing
Details
201-159-0
78-93-3
2018
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
202-496-6
96-29-7
2013
Germany
CMR
Sensitiser
Consumer use
Cumulative exposure
High RCR
Wide dispersive use
Concluded
Details
205-480-7
141-32-2
2013
Sweden
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
700-992-1
-
2014
Norway
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
215-609-9
1333-86-4
2025
France
Carcinogenic
Suspected Reprotoxic
Consumer use
Cumulative exposure
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
200-843-6
75-15-0
2013
France
CMR
Potential endocrine disruptor
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Concluded
Details
200-262-8
56-23-5
2012
France
CMR
Exposure of workers
High (aggregated) tonnage
Concluded
Details
215-150-4
1306-38-3
Germany
Suspected Carcinogenic
Suspected Mutagenic
Other hazard based concern
Cumulative exposure
Exposure of environment
Wide dispersive use
Withdrawn
Details
203-628-5
108-90-7
2023
Netherlands
Suspected Mutagenic
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
200-817-4
74-87-3
2012
Italy
CMR
Potential endocrine disruptor
High RCR
Concluded
Details
215-160-9
1308-38-9
2019
France
Suspected Reprotoxic
Suspected Sensitiser
High (aggregated) tonnage
Concluded
Details
226-394-6
5392-40-5
2015
Sweden
Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-376-6
106-23-0
2015
Sweden
Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.